QUANTITATION OF IMMUNOSUPPRESSION BY FLOW CYTOMETRIC MEASUREMENT OF THE CAPACITY OF T CELLS FOR INTERLEUKIN-2 PRODUCTION1
- 1 April 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 65 (8) , 1066-1071
- https://doi.org/10.1097/00007890-199804270-00010
Abstract
Methods to quantitate the effects of immunosuppressive drugs on immune reactivity might be helpful for monitoring immunosuppressive treatment. Cyclosporine (CsA) inhibits the induction of cytokine synthesis in T cells, and measurement of interleukin (IL)-2 production might constitute a parameter of this drug's effect. We determined the percentages of CD4 + and CD8 + lymphocytes producing IL-2 upon stimulation by phorbol myristate acetate and calcium ionophore in whole blood culture, using immunostaining of intracytoplasmatic and membrane markers, followed by multiparameter flow cytometry. A total of 38 clinically stable transplant patients on various immunosuppressive protocols were studied. The percentage of CD4 + T cells producing IL-2 was strongly reduced in patients compared with healthy controls (23%[range, 3-68%] vs. 59.0% [range, 41-70%]; P =0.000035). The percentage of CD4 + T cells producing IL-2 was negatively correlated with the CsA level(R c =-0.0821, P =0.00002297) but not with prednisolone or azathioprine doses. Fewer CD8 + T cells produced IL-2 in transplant patients compared with controls, but the difference failed to reach statistical significance. The percentage of CD8 + T cells capable of producing IL-2 was inversely correlated to CsA levels(R c =-0.0375, P =0.0011). These data suggest that the functional effects of CsA in transplant recipients can be quantitatively determined and that the capacity of CD4 + T cells to produce IL-2 upon stimulation constitutes a functional parameter of CsA effects on the immune system. Prospective studies are required to determine whether this method is useful for clinical monitoring.Keywords
This publication has 18 references indexed in Scilit:
- Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.Journal of Clinical Investigation, 1995
- CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTSTransplantation, 1995
- CsA LEVELS IN THE EARLY POSTTRANSPLANT PERIOD—PREDICTIVE OF CHRONIC REJECTION IN LIVER TRANSPLANTATION?Transplantation, 1995
- The Pharmacology of AzathioprineAnnals of the New York Academy of Sciences, 1993
- Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reactionHuman Immunology, 1993
- Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.Journal of Clinical Investigation, 1993
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Assessment of Cytokines by Immunofluorescence and the Paraformaldehyde‐Saponin ProcedureImmunological Reviews, 1991
- CHRONIC REJECTION IN PRIMARY RENAL ALLOGRAFT RECIPIENTS UNDER CYCLOSPORINE-PREDNISONE IMMUNOSUPPRESSIVE THERAPYTransplantation, 1991
- Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the bloodJournal of Pharmacy and Pharmacology, 1982